Close Menu
  • Home
  • AI & Technology
  • Politics
  • Business
  • Cryptocurrency
  • Sports
  • Finance
  • Fitness
  • Gadgets
  • World
  • Marketing

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

Ethereum Price Lags Despite All-Time High In Daily Transactions

August 6, 2025

Bitcoin Bull Run Already Over? Whales Are Bailing, Retail’s Late

August 6, 2025

Trump and Apple CEO Tim Cook Announce $600 Billion Total Investment in America

August 6, 2025
Facebook X (Twitter) Instagram
  • Home
  • About US
  • Advertise
  • Contact US
  • DMCA
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram
MNK NewsMNK News
  • Home
  • AI & Technology
  • Politics
  • Business
  • Cryptocurrency
  • Sports
  • Finance
  • Fitness
  • Gadgets
  • World
  • Marketing
MNK NewsMNK News
Home » Post-Hims & Hers Breakup, Novo Nordisk Strengthens WeightWatchers Ties
Fitness

Post-Hims & Hers Breakup, Novo Nordisk Strengthens WeightWatchers Ties

MNK NewsBy MNK NewsJuly 2, 2025No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


With a pharma giant in its corner, WeightWatchers is mounting a comeback, relying on FDA-approved GLP-1 medications

WeightWatchers is deepening its partnership with Novo Nordisk to expand access to Wegovy, a blockbuster, FDA-approved GLP-1 weight loss drug, through the WeightWatchers Clinic online platform.

The announcement comes on the heels of Novo Nordisk’s recent high-profile split with telehealth platform Hims & Hers, a rather short-lived partnership that ended amid tensions over compounded versions of semaglutide. Ironically, the move underscores WeightWatchers’ position as one of the few platforms publicly committed to prescribing only FDA-approved weight loss medications, at a time when the company is navigating Chapter 11 bankruptcy in an effort to cut debt and reposition itself for long-term growth.

While WeightWatchers undergoes restructuring, the storied weight management company is moving forward with efforts to streamline access and improve the member experience. The expanded agreement with the pharmaceutical giant simplifies prescriptions through NovoCare Pharmacy and enables home delivery via CenterWell Pharmacy, as well as bundled pricing, shipment tracking and inventory visibility.

As part of the rollout, Novo Nordisk is offering a limited-time savings program for WeightWatchers Clinic members, with eligible cash-pay users able to access Wegovy for $299 through July 31.

A phone sitting on a table with the WeightWatchers app loaded.
credit: WeightWatchers

“By deepening our collaboration with Novo Nordisk, we are helping more people access the FDA-approved treatment they deserve, delivered within a holistic clinical model proven to support real, sustainable and improved health outcomes,” WeightWatchers’ chief commercial officer Scott Honken said. “In a market increasingly cluttered with hype and shortcuts, WeightWatchers remains the trusted leader, bringing together access to safe, FDA-approved medication and best-in-class lifestyle support, setting the bar for the gold standard of responsible weight management.”

Beyond expanded access and pricing incentives, WeightWatchers and Novo Nordisk will explore joint research efforts to assess the impact of pairing Wegovy with WeightWatchers’ behavioral and nutrition programs.

See Also


“As we work to expand access to life-changing, FDA-approved treatments like Wegovy, it is essential that we partner with organizations that share our values and focus on improving long-term outcomes,” Novo Nordisk executive vice president of U.S. operations Dave Moore said. “In a space crowded with quick-fix promises, and unapproved and unsafe compounded medications, we are excited to collaborate with WeightWatchers and their science-backed, responsible approach to care.”

“Their focus on behavioral support, real-world outcomes, and FDA-approved treatment aligns with our values,” Moore added.” We believe this expanded collaboration will help more people access safe, effective, and sustainable weight management.”

Zooming out, the rise of GLP-1 use is changing the economics of weight loss spending (and fast). A new study published in JAMA shows consumer spending on GLP-1 drugs like Wegovy and Ozempic surged from $13.7 billion in 2018 to $71.7 billion in 2023 in the U.S., with the steepest increase between 2022 and 2023.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
MNK News
  • Website

Related Posts

Vitamin Shoppe Names First-Ever Chief Strategy Officer

August 6, 2025

Everyday Dose Expands Into 1,500+ Target Stores

August 6, 2025

Jennifer Jacobs on Her New Ladder Strength Training Program

August 6, 2025
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Pakistan women lose by 11 runs in first Ireland T20 – Sport

August 6, 2025

Pakistan women target 143 in first Ireland T20 to continue winning momentum – Sport

August 6, 2025

Pakistan women win toss and bowl in first Ireland T20 – Sport

August 6, 2025

Porto ‘legend’ Jorge Costa dies aged 53 – Sport

August 6, 2025
Our Picks

Ethereum Price Lags Despite All-Time High In Daily Transactions

August 6, 2025

Bitcoin Bull Run Already Over? Whales Are Bailing, Retail’s Late

August 6, 2025

Is The Bitcoin Bull Run In Jeopardy? Expert Reveals Strategy’s Alleged Plan To Sell All BTC Holdings

August 6, 2025

Recent Posts

  • Ethereum Price Lags Despite All-Time High In Daily Transactions
  • Bitcoin Bull Run Already Over? Whales Are Bailing, Retail’s Late
  • Trump and Apple CEO Tim Cook Announce $600 Billion Total Investment in America
  • Trump says he plans to put a 100% tariff on computer chips
  • Is The Bitcoin Bull Run In Jeopardy? Expert Reveals Strategy’s Alleged Plan To Sell All BTC Holdings

Recent Comments

No comments to show.
MNK News
Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
  • Home
  • About US
  • Advertise
  • Contact US
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 mnknews. Designed by mnknews.

Type above and press Enter to search. Press Esc to cancel.